Booz Allen Hamilton Holding Co. (NYSE:BAH) Given Average Recommendation of “Buy” by Analysts

Share on StockTwits

Booz Allen Hamilton Holding Co. (NYSE:BAH) has been assigned a consensus recommendation of “Buy” from the thirteen brokerages that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and nine have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $67.30.

BAH has been the topic of a number of research analyst reports. Jefferies Financial Group lifted their target price on Booz Allen Hamilton from $61.00 to $69.00 and gave the stock an “outperform” rating in a report on Wednesday, May 29th. Zacks Investment Research raised Booz Allen Hamilton from a “hold” rating to a “buy” rating and set a $71.00 target price on the stock in a report on Friday, June 28th. Morgan Stanley lifted their target price on Booz Allen Hamilton from $70.00 to $76.00 and gave the stock an “overweight” rating in a report on Wednesday, August 21st. Cowen reaffirmed a “buy” rating and set a $71.00 target price on shares of Booz Allen Hamilton in a report on Monday, July 29th. Finally, Citigroup lifted their price target on Booz Allen Hamilton from $65.00 to $71.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 30th.

In other Booz Allen Hamilton news, insider Horacio Rozanski sold 31,000 shares of Booz Allen Hamilton stock in a transaction dated Monday, July 15th. The stock was sold at an average price of $68.77, for a total transaction of $2,131,870.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Lloyd Howell, Jr. sold 74,279 shares of Booz Allen Hamilton stock in a transaction dated Monday, July 8th. The shares were sold at an average price of $67.19, for a total value of $4,990,806.01. The disclosure for this sale can be found here. Insiders sold a total of 197,008 shares of company stock worth $13,573,421 in the last three months. 2.60% of the stock is currently owned by company insiders.

A number of large investors have recently added to or reduced their stakes in the business. Hanseatic Management Services Inc. grew its stake in Booz Allen Hamilton by 1.1% during the 2nd quarter. Hanseatic Management Services Inc. now owns 14,987 shares of the business services provider’s stock valued at $992,000 after acquiring an additional 167 shares in the last quarter. Kings Point Capital Management grew its stake in Booz Allen Hamilton by 2.3% during the 2nd quarter. Kings Point Capital Management now owns 8,474 shares of the business services provider’s stock valued at $561,000 after acquiring an additional 193 shares in the last quarter. Jennison Associates LLC grew its stake in Booz Allen Hamilton by 2.2% during the 2nd quarter. Jennison Associates LLC now owns 10,440 shares of the business services provider’s stock valued at $691,000 after acquiring an additional 224 shares in the last quarter. AGF Investments LLC grew its stake in Booz Allen Hamilton by 1.0% during the 2nd quarter. AGF Investments LLC now owns 22,947 shares of the business services provider’s stock valued at $1,519,000 after acquiring an additional 225 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. grew its stake in Booz Allen Hamilton by 1.2% during the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 19,786 shares of the business services provider’s stock valued at $1,310,000 after acquiring an additional 234 shares in the last quarter. 92.02% of the stock is currently owned by institutional investors.

NYSE:BAH traded up $1.48 during mid-day trading on Thursday, reaching $71.02. 28,141 shares of the stock were exchanged, compared to its average volume of 1,024,980. The business has a fifty day moving average price of $72.38 and a 200 day moving average price of $63.83. The firm has a market capitalization of $9.66 billion, a PE ratio of 25.74, a PEG ratio of 1.85 and a beta of 0.92. Booz Allen Hamilton has a 1-year low of $43.24 and a 1-year high of $78.01. The company has a current ratio of 1.75, a quick ratio of 1.75 and a debt-to-equity ratio of 3.14.

Booz Allen Hamilton (NYSE:BAH) last released its earnings results on Monday, July 29th. The business services provider reported $0.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.72 by $0.11. The firm had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.79 billion. Booz Allen Hamilton had a return on equity of 59.44% and a net margin of 6.27%. Booz Allen Hamilton’s revenue was up 10.8% compared to the same quarter last year. During the same period in the previous year, the company earned $0.72 earnings per share. On average, sell-side analysts forecast that Booz Allen Hamilton will post 3.06 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Wednesday, August 14th were paid a $0.23 dividend. The ex-dividend date of this dividend was Tuesday, August 13th. This represents a $0.92 dividend on an annualized basis and a yield of 1.30%. Booz Allen Hamilton’s dividend payout ratio is currently 33.33%.

Booz Allen Hamilton Company Profile

Booz Allen Hamilton Holding Corporation provides management and technology consulting, engineering, analytics, digital, mission operations, and cyber solutions to governments, corporations, and not-for-profit organizations in the United States and internationally. The company offers consulting solutions for various domains, business strategies, human capital, and operations.

Recommended Story: Why is the LIBOR significant?

Analyst Recommendations for Booz Allen Hamilton (NYSE:BAH)

Receive News & Ratings for Booz Allen Hamilton Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Booz Allen Hamilton and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

ValuEngine Upgrades Blackbaud  to “Strong-Buy”
ValuEngine Upgrades Blackbaud to “Strong-Buy”
Anavex Life Sciences  Upgraded to “Buy” by ValuEngine
Anavex Life Sciences Upgraded to “Buy” by ValuEngine
Cantor Fitzgerald Boosts Adverum Biotechnologies  Price Target to $8.00
Cantor Fitzgerald Boosts Adverum Biotechnologies Price Target to $8.00
Citigroup Trims Mplx  Target Price to $32.00
Citigroup Trims Mplx Target Price to $32.00
Evofem Biosciences  Downgraded to Hold at Zacks Investment Research
Evofem Biosciences Downgraded to Hold at Zacks Investment Research
Zacks Investment Research Upgrades Cushman & Wakefield  to “Hold”
Zacks Investment Research Upgrades Cushman & Wakefield to “Hold”


 
© 2006-2019 Zolmax.